Delayed hemolytic transfusion reaction in children with sickle cell disease. - Wikidata - wikimedia - TriplyDB

Delayed hemolytic transfusion reaction in children with sickle cell disease.

Delayed hemolytic transfusion reaction in children with sickle cell disease.

http://www.wikidata.org/entity/Q35018501

about

A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.Alloimmunization in patients with sickle cell disease in French Guiana."Sickle Cell Disease in the Emergency Department: Atypical Complications and Management"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients.Indications and complications of transfusions in sickle cell disease.Challenges of alloimmunization in patients with haemoglobinopathies.Transfusion in critically ill children: an ongoing dilemma.How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK(b) in intermediate β-thalassemia patient in Tabriz.Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.Profound sustained reticulocytopenia and anaemia in an adult patient with sickle cell disease.Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.Genotyping in Sickle Cell Disease Patients: The French Strategy

P2860

Q33440070-A554ABEB-817F-4ED8-8216-E5A7C65D5CFE Q35097675-E8A603DA-4438-47C9-A85A-503A01119053 Q35212165-F3847957-EAF2-4E15-8133-9C1405A7F60D Q36106307-2B5FC38A-2FD7-4B87-B19B-B96E2927FF92 Q37588941-D02D0269-5FE4-4F22-9726-C74BD17EA0A5 Q38008292-18871B08-B5A1-4630-8813-BF7B5D328D25 Q38049189-29F0CDB8-F80E-45F9-AA6A-ED50609A5191 Q38108382-938FFD85-4A50-4555-B3EA-4D8E66CE50E5 Q38476241-719F85C6-64AA-485C-9FA3-57B0A9AC63D8 Q38666286-E8905B43-5FAD-42BC-8F0D-6407DDB14BC4 Q38930968-EF6C98B8-7C40-480F-BBB3-2E3DE5C0FF39 Q38949082-F86AA540-629B-48E6-8F7F-88474CF155E4 Q40166101-6F99F1BF-4215-413F-82EF-5DA06FE45116 Q40235315-99B6336F-F9D3-4107-98BF-036AF7A7D5AE Q41253789-1A19C536-9847-4837-9994-E77AF93ED5F4 Q46633837-47F5B03A-E24A-4D03-9525-2E524F55FD49 Q48326469-06222E75-E50F-4FA6-B572-939069FD5708 Q50218898-08C4A7FD-7B40-48CB-B1EF-525D28495E13 Q50437265-3897E844-9D8B-47D1-96D3-827DC8DFF364 Q50451822-4DAACD34-CA55-4042-B324-E11F606E2659 Q51068174-522C38E4-6268-4186-9139-D2382B2A0A22 Q51654073-B061060E-3121-499B-81C8-B6B086A68C55 Q51678751-0BD83D74-7E22-4F2C-8B82-B289AC373A0F Q53686375-4479BA50-06DF-410F-9423-E32AF9A683B5 Q55427971-97B4FEE3-F520-4A1C-88F5-2597BDFC0166 Q57142948-03ABFFBE-F86E-4579-8088-CEC972A581C3

P2860

Delayed hemolytic transfusion reaction in children with sickle cell disease.

http://www.wikidata.org/entity/Q35018501

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@ast

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@en

type

label

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@ast

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@en

prefLabel

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@ast

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@en

P1433

Q35018501-EF8534CD-0422-4833-92A7-56BD2DDADED4

P1476

Q35018501-4A279B2A-6B4D-4B44-9FFF-EC9557A60C2A

P2093

Q35018501-0C652623-6376-40A0-8ECE-AFFB4985F83A

Q35018501-3B0D1651-108F-4D71-A275-967891344A45

Q35018501-59A8822A-E558-497C-85AB-2DDA9B4A1F80

Q35018501-6560F239-3E44-4245-87D5-2F3536B7D40D

Q35018501-7EA6A74B-6817-49ED-BA28-791DEF670CA3

Q35018501-92E6B0FB-FD68-4D4E-A260-3CAD7FB22C53

Q35018501-AB7C7BC8-E26B-4169-AE4B-FC4303DB5872

Q35018501-C62CA0B7-4F96-4984-991A-00AB0AA8DBA5

Q35018501-D53C6AD6-A672-4571-8451-D787F0F7CAD1

P2860

Q35018501-0085AF2B-BF30-49F4-80DD-DDB96E32F8D0

Q35018501-0EED9E8D-9F9E-450A-859C-7D281A83F218

Q35018501-13CD90A4-9307-4C0E-BD50-C1B9F54603BE

Q35018501-1B4959B3-3687-437E-A6CF-7B8726E6854E

Q35018501-24957344-3EDB-4E3C-808B-602D2C2EEBCC

Q35018501-26FC2023-D838-40B5-903F-2DE2900B7270

Q35018501-31096784-E183-47D9-8E63-1F16905F0292

Q35018501-3899E3EA-23CD-4A1D-BD3E-A1F141BF0EEE

Q35018501-63AB7B55-FEE4-49F8-8089-DB567BF35848

Q35018501-6A328C83-EB12-420A-B480-59FEE1269C1E

P304

Q35018501-47FF5C5B-5B0C-42DD-8EB5-AF952646D7AC

P31

Q35018501-99218DE7-4CDA-45CB-BE85-10325AEA13C1

P356

Q35018501-4F2F457A-0189-4390-A174-314B2F073C27

P433

Q35018501-4566D614-1D35-4F8A-AEAA-8C1FBB0066E4

P478

Q35018501-509BC7D4-7AA9-42E2-9B8A-502C01A13B56

P577

Q35018501-641F76CB-9092-4638-9F08-704587FEF38D

P5875

Q35018501-CC0C9397-948B-4766-BEBC-F71D05AECB8E

P698

Q35018501-BB0671FC-15ED-4E2B-873F-C1D435A8EC28

P921

Q35018501-530BABD8-5C7A-450C-98F6-CF769E067A23

P932

Q35018501-95B34E51-888A-4E0E-B77D-64F919A8EC24

P356

HAEMATOL.2010.038307

P1433

P1476

Delayed hemolytic transfusion reaction in children with sickle cell disease.

@en

P2093

Béatrice Pellegrino

http://www.w3.org/2001/XMLSchema#string

Christophe Piguet

http://www.w3.org/2001/XMLSchema#string

Claire Heilbronner

http://www.w3.org/2001/XMLSchema#string

France Noizat-Pirenne

http://www.w3.org/2001/XMLSchema#string

Mariane de Montalembert

http://www.w3.org/2001/XMLSchema#string

Marie-Dominique Dumont

http://www.w3.org/2001/XMLSchema#string

Oussama Charrara

http://www.w3.org/2001/XMLSchema#string

Valentine Brousse

http://www.w3.org/2001/XMLSchema#string

Valérie Soussan

http://www.w3.org/2001/XMLSchema#string

P2860

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?

Delayed hemolytic transfusion reaction in sickle cell disease

Indications for red cell transfusion in sickle cell disease.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.

Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.

Sickle cell anemia as an inflammatory disease

Cell response to surgery.

Anesthetics, immune cells, and immune responses.

P304

801-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2010.038307

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49844720

http://www.w3.org/2001/XMLSchema#string

P698

21330322

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3105640

http://www.w3.org/2001/XMLSchema#string